We can speculate that loss of TTP could contribute to the remodeling of the surrounding stroma through the regulation of key mediators known to promote angiogenesis (such as VEGF, PGF, or MMPs) or activate cancer-associated fibroblasts (such as activinβA; ref. 40). The gene discussed is PGF; the disease is cancer.